Ibogaine effects on sweet preference and amphetamine induced locomotion: Implications for drug addiction

Behavioural Brain Research

Volumn 89, Issue 1-2, 1997, Pages 99-106

  Blackburn, James R ^a   Szumlinski, Karen K ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Amphetamine; Dopamine; Ibogaine; Incentive; Motivation; Rat; Reward; Sensitization

Indexed keywords

AMPHETAMINE; FLAVORING AGENT; GLUCOSE; IBOGAINE; SACCHARIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT; REINFORCEMENT; SENSITIZATION; SWEETNESS; TASTE PREFERENCE;

AMPHETAMINE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CUES; DOPAMINE; DOPAMINE ANTAGONISTS; DRUG INTERACTIONS; FOOD PREFERENCES; IBOGAINE; MALE; MOTOR ACTIVITY; PSYCHOTROPIC DRUGS; RATS; REWARD; SUBSTANCE-RELATED DISORDERS; SYNAPTIC TRANSMISSION; TASTE;

EID: 0031422017     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(97)00050-8     Document Type: Article

References (70)

1. Beninger R.J., Hoffman D.C., Mazurski E.J. Receptor subtype-specific dopaminergic agents and conditioned behavior. Neurosci. Biobehav. Rev. 13:1989;113-122.
2. Benwell M.E.M., Balfour D.J.K. The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br. J Pharmacol. 105:1992;849-856.
3. Blackburn J.R., Phillips A.G., Fibiger H.C. Dopamine and preparatory behavior I: Effects of pimozide. Behav. Neurosci. 101:1987;352-360.
4. Blackburn J.R., Pfaus J.G., Phillips A.G. Dopamine functions in appetitive and defensive behaviours. Prog. Neurobiol. 39:1992;247-279.
5. Cappendijk S.L., Dzoljic M.R. Inhibitory effects of ibogaine on cocaine selfadministration in rats. Eur. J. Pharmacol. 241:1993;261-265.
6. Castaneda E., Becker J.B., Robinson T.E. The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KCI and electrical stimulation evoked striatal dopamine release in vitro. Life Sci. 42:1988;2447-2456.
7. Childress A.R., McLennan A.T., Ehrrnan R., O'Brien C.P. Classically conditioned responses in opioid and cocaine dependence: a role in relapse? NIDA Res. Monogr. 84:1988;25-43.
8. Clarke P.B.S., Kumar R. The effects of nicotine on locomotor activity in nontolerant and tolerant rats. Br. J. Pharmacol. 78:1983;329-337.
9. Cunningham C.L., Nobel D. Conditioned activation induced by ethanol: Role in sensitization and conditioned place preference. Pharmacol. Biochem. Behav. 43:1992;307-313.
10. Deecher D.C., Teitler M., Soderlund D.M., Bornmann W.G., Kuehne M.E., Glick S.D. Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies. Brain Res. 571:1992;242-247.
11. Dhahair, H.I. (1971) A Comparative Study of the Toxicity of Ibogaine and Serotonin, Doctoral thesis (Ann Arbor, Michigan, U.S.A., University Microfilm International) 7125-7341.
12. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A. 85:1988;5274-5278.
13. Eikelboom R., Stewart J. Conditioning of drug-induced physiological responses. Psychol. Rev. 89:1982;507-528.
14. Everitt B.J. Sexual motivation: A neural and behavioural analysis ofthe mechanisms underlying appetitive and copulatory responses of male rats. Neurosci. Biobehav. Rev. 14:1990;217-232.
15. Fibiger, H.C., Phillips, A.G., Reward, motivation, cognition: psychobiology of mesotelencephalic dopamine systems, in: V.B. Mountcastle, F.E. Bloom, S.R. Geiger (Eds.), Handbook of Physiology: The Nervous System, Vol. 4., American Physiological Society, Bethesda, MD., 1986, pp. 647-675.
16. Geary N., Smith G.P. Pimozide decreases the positive reinforcing effect of sham fed sucrose in the rat. Pharmacol. Biochem. Behav. 22:1985;787-790.
17. Glick S.D., Kuehne M.E., Raucci J., Wilson T.E., Larson D., Keller R.W. Jr., Carlson J.N. Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum. Brain Res. 657:1994;14-22.
18. Glick S.D., Rossman K., Steindorf S., Maisonneuve I.M., Carlson J.N. Effects and aftereffects of ibogaine on morphine self-administration in rats. Eur. J. Pharmacol. 195:1991;341-345.
19. Glick S.D., Rossman K., Wang S., Dong N., Keller R.W. Jr. Local effects of ibogaine on extracellular levels of dopamine and its metabolises in nucleus accumbens and striatum: interactions with D-amphetamine. Brain Res. 628:1993;201-208.
20. Harsing L.G., Sershen H., Lajtha A. Evidence that ibogaine releases dopamine from the cytoplasmic pool in isolated mouse striatum. J. Neural. Transm. 96:1994;215-225.
21. Hiroi N., White N.M. The lateral nucleus of the amygdala mediates expression of the amphetamine-produced conditioned place preference. J. Neurosci. 11:1992;2107-2116.
22. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
23. Keetner S.M., Glick S.D. Ibogaine antagonism of morphine-induced hyperactivity: enhancement by prior morphine exposure and role of kappa opioid receptors. Soc. Neurosci. Abstr. 20:1994;502.5.
24. Kelly P.H., Moore K.E. Mesolimbic dopaminergic neurones in the rotational model of nigrostriatal function. Nature. 263:1976;695-696.
25. Kita T., Okamoto M., Nakashima T. Nicotine-induced sensitization to ambulatory stimulant effect produced by daily administration into the ventral segmental area and the nucleus accumbens in rats. Life Sci. 50:1992;583-590.
26. C. Kornetsky, L.J. Porrino, Brain mechanisms of drug-induced reinforcement, in: C.P. O Brien, J.H. Jaffe (Eds.), Addictive States, Raven Press, New York, 1992, pp. 59-77.
27. R. Kuczenski, D.S. Segal, Psychomotor stimulant-induced sensitization: Behavioral and neurochemical correlates, in: P.W. Kalivas, C.D. Barnes (Eds.), Sensitization in the Nervous System, Telford, Caldwell NJ, 1988, pp. 175-205.
28. M.J. Kuhar, Molecular pharmacology of cocaine: a dopamine hypothesis and its implications, in: G.R. Bock, J. Whelan (Eds.) Cocaine: Scientific and Social Dimensions, Wiley, Chichester, 1992, pp. 81-89.
29. Lee Y.W., Rezvani A.H., Overstreet D.H. Ibogaine attenuates alcohol intake in alcohol drinking rats. Soc. Neurosci. Abstr. 90:1994;658.10.
30. Ljungberg T., Apicella P., Schultz W. Responses of monkey dopamine neurons during learning of behavioral reactions. J. Neurophysiol. 67:1992;145-163.
31. Lotsof (1985), U.S. Patent No. 4 499 096.
32. Lotsof (1986), U.S. Patent No. 4 587 243.
33. Lotsof (1989), U.S. Patent No. 4 857 523.
34. Lotsof (1991), U.S. Patent No. 5 026 697.
35. Maisonneuve I.M., Glick S.D. Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behavior. Eur. J. Pharmacol. 212:1992;263-266.
36. Maisonneuve I.M., Keller R.W. Jr., Glick S.D. Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study. Eur. J. Pharmacol. 199:1991;35-42.
37. Maisonneuve I.M., Keller R.W. Jr., Glick S.D. Interactions of ibogaine and D-amphetamine: in vivo microdialysis and motor behavior in rats. Brain Res. 579:1992;87-92.
38. Maisonneuve I.M., Rossman K.L., Keller R.W. Jr., Glick S.D. Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats. Brain Res. 575:1992;69-73.
39. G.J. Mogenson, A.G. Phillips, Motivation: A psychological construct in search of a physiological substrate, in: J.M. Sprague, A.N. Epstein (Eds.), Progress in Psychobiology and Physiological Psychology, Vol 6., Academic Press, New York, 1976, pp. 189-243.
40. Muscat R., Willner P. Effects of dopamine receptor antagonists on sucrose consumption and preference. Psychopharmacology. 99:1989;98-102.
41. Pearl S.M., Herrick-Davis K., Teitler M., Glick S.D. Radioligand-binding study of noribogaine, a likely metabolite of ibogaine. Brain Res. 675:1995;342-344.
42. Pearl S.M., Johnson D.W., Glick S.D. Prior morphine exposure enhances ibogaine antagonism of morphine-induced locomotor stimulation. Psychopharmacology. 121:1995;470-475.
43. Pfaus J.G., Damsma G., Nomikos G.G., Wenkstern D.G., Blaha C.D., Phillips A.G., Fibiger H.C. Sexual behavior enhances central dopamine transmission in the male rat. Brain Res. 530:1990;345-348.
44. Pfaus J.G., Phillips A.G. Differential effects of dopamine receptor antagonists on the sexual behavior of male rats. Psychopharmacology. 98:1989;363-368.
45. Phillips A.G., Atkinson L.J., Blackburn J.R., Blaha C.D. Increased extracellular dopamine in the nucleus accumbens of the rat elicited by a conditional stimulus for food: An electrochemical study. Can. J. Physiol. Pharmacol. 71:1993;387-393.
46. Popik P., Layer R.T., Skolnick P. 100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug. Pharmacol. Rev. 47:1995;235-253.
47. Rezvani A.H., Overstreet D.H., Lee Y.W. Attenuation of alcohol intake by ibogaine in three strains of alcohol-preferring rats. Pharmacol. Biochem. Bahav. 52:1995;15-620.
48. Robbins T.W., Everitt B.J. Functional studies of the central catecholamines. Int. Rev. Neurobiol. 23:1982;303-365.
49. Robbins T.W., Cador M., Taylor J.R., Everitt B.J. Limbic-striatal interactions in reward-related processes. Neurosci. Biobehav. Rev. 13:1989;155-162.
50. Robinson T.E., Becker J.B. Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro. Eur. J. Pharmacol. 85:1982;253-254.
51. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 396:1986;157-198.
52. Robinson T.E., Berridge K.C. The neural basis of drug craving an incentive sensitization theory of addiction. Brain Res. Rev. 18:1993;247-291.
53. Robinson T.E., Jurson P.A., Bennett J.A., Bentgen K.M. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res. 462:1988;211-222.
54. J.D. Salamone, The actions of neuroleptic drugs on appetitive instrumental behaviors, in: L.L. Iversen, S.D. Iversen, S.H. Snyder (Eds.), Handbook of Psychopharmacology, Vol 19 Plenum Press, New York, 1987, pp. 575-608.
55. Sershen H., Hashim A., Harsing L.G., Lajtha A. Ibogaine antagonizes cocaine induced locomotor stimulation in mice. Life Sci. 50:1992;1079-1086.
56. Sershen H., Harsing L.G. Jr., Hashim A., Lajtha A. Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in rats. Life Sci. 51:1992;1003-1011.
57. Sershen H., Hashim A., Lajtha A. Ibogaine reduces preference for cocaine consumption in C57BL/6By mice. Pharmacol. Biochem. Behav. 47:1994;13-19.
58. Sheppard S.G. A preliminary investigation of ibogaine: case reports and recommendations for further study. J. Subst. Abuse Treat. 11:1994;379-385.
59. Shuster L., Webster G.W., Wu G. Increased running response to morphine in morphine-pretreated mice. J. Pharmacol. Exper. Ther. 192:1975;64-67.
60. Smith J.C., Foster D.F. Some determinants of intake of glucose+saccharin solutions. Physiol. Behav. 25:1980;127-133.
61. G.P. Smith, Dopamine and food reward, in: S. Fluharty, A.R. Morrison, J.M. Sprague, E. Stellar (Eds.), Progress in Psychobiology and Physiologicat Psychology, Vol. I6, Academic Press, New York, 1995, pp. 99-144.
62. E. Stellar, Brain mechanisms in hedonic processes, in: D.M. Pfaff (Ed.), The Physiological Basis of Motivation, Springer Verlag, New York, 1982, pp. 377-407.
63. Stevens J., Livermore A., Cronan J. Effects of deafening and blindfolding on amphetamine induced stereotypy in the cat. Physiol. Behav. 18:1977;809-812.
64. J. Stewart, Conditioned stimulus control of the expression of sensitization of the behavioral activating effects of opiate and stimulant drugs, in: I. Garmezano, E.A. Wasserman (Eds.), Learning and Memory: The Behavioral and Biological Substrates, Erlbaum, New Jersey, 1991, pp. 129-151.
65. Stewart J., Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav. Pharmacol. 4:1993;289-312.
66. Weingarten H.P., Duong A., Gowans S., Elston D. The interpretation of sham feeding data: Curve shift studies. Soc. Neurosci. Abstr. 16:1990;912.
67. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-492.
68. Wise R.A., Rompre P-P. Brain dopamine and reward. Ann. Rev. Psychol. 40:1989;191-225.
69. Xenakis S., Sclafani A. The effects of pimozide on the consumption of a palatable saccharin-glucose solution in the rat. Pharmacol. Biochem. Behav. 15:1981;435442.
70. Zetler G., Singbarth G., Schlosser L. Cerebral pharmacokinetics of tremor producing harmala and iboga alkaloids. Pharamcology. 7:1972;237.